Invention Application
- Patent Title: MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
-
Application No.: US14170199Application Date: 2014-01-31
-
Publication No.: US20140148573A1Publication Date: 2014-05-29
- Inventor: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik , Ying Sun , Dong Liu , Yonghua Gai , Yat Sun Or , Seble H. Wagaw , Kenneth Engstrom , Tim Grieme , Ahmad Sheikh , Jianzhang Mei
- Applicant: Enanta Pharmaceuticals, Inc. , AbbVie, Inc.
- Applicant Address: US MA Watertown US IL North Chicago
- Assignee: Enanta Pharmaceuticals, Inc.,AbbVie, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.,AbbVie, Inc.
- Current Assignee Address: US MA Watertown US IL North Chicago
- Main IPC: C07K1/113
- IPC: C07K1/113
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US09309279B2 Macrocyclic hepatitis C serine protease inhibitors Public/Granted day:2016-04-12
Information query
